Caribou Biosciences, Inc.

NASDAQ:CRBU

Biotechnology

Healthcare
$0.49 -2.74%

-$0.05 today

Market cap
$52.47M
Beta
2.33
P/E (TTM)
-1.1
EPS (TTM)
-$1.39
52W Low $1.20High $3.54

Volume 1.01M

Average 1.83M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$110.99M

FY 2025 · Annual

Investing Cash Flow

$102.24M

FY 2025 · Annual

+18.0% YoY

Financing Cash Flow

$4.82M

FY 2025 · Annual

-71.2% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(66.92M)(99.42M)(102.07M)(149.11M)(148.13M)
Depreciation & Amortization984K3.64M3.53M3.93M3.65M
Deferred Income Tax0(95K)00(548K)
Stock-Based Compensation3.45M11.72M13.75M16.71M12.68M
Change in Working Capital29.07M(4.11M)(7.32M)(5.11M)(484K)
Accounts Receivables(2.96M)3.46M805K608K272K
Inventory00000
Accounts Payables1.14M(2.72M)1.82M(354K)3.25M
Other Working Capital30.89M(4.85M)(9.94M)(5.37M)(4.01M)
Other Non-Cash Items904K9.02M(1.18M)(4.61M)21.84M
Operating Cash Flow(32.52M)(90.97M)(93.29M)(138.2M)(110.99M)
Capital Expenditures(3.12M)(6.45M)(11.61M)(6.51M)(1.36M)
Acquisitions (Net)00000
Purchases of Investments(173.28M)(339.06M)(394.76M)(304.39M)(150.37M)
Sales of Investments0252.87M338.19M397.49M252.83M
Other Investing Activities(1M)(600K)0(1.61M)1.14M
Investing Cash Flow(176.4M)(93.25M)(68.18M)86.61M102.24M
Debt Repayment1.03M0000
Common Stock Issued321.02M2.13M152.72M15.19M4.82M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities2.55M01.58M1.53M0
Financing Cash Flow433.43M2.13M154.3M16.72M4.82M
Effect of Forex Changes00000
Net Change in Cash224.51M(182.08M)(7.18M)(34.87M)(3.93M)
Free Cash Flow(35.64M)(97.42M)(104.9M)(144.71M)(112.35M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$148.1M
+ D&A$3.6M
+ Stock-Based Comp$12.7M
- Deferred Tax-$548.0K
- Working Capital-$484.0K
+ Other Non-Cash$21.8M
= Operating Cash Flow-$111.0M
- Capex-$1.4M
= Free Cash Flow-$112.4M

Analysis

FY2025 free cash flow is -$112.4M. FCF conversion is 75.8% of net income. Operating cash flow was -$111.0M, with capex of -$1.4M. The largest bridge item is Other Non-Cash at $21.8M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportOct 6, 2026
8-KCurrent reportAug 13, 2026
10-QQuarterly reportAug 13, 2026
SC 13GSC 13G filingJul 27, 2026
8-KCurrent reportJun 18, 2026

Does CRBU generate free cash flow?

Caribou Biosciences, Inc. (CRBU) generated -$112.35M of free cash flow in fiscal 2025.

How much operating cash flow does CRBU produce?

Operating cash flow was -$110.99M, before capital expenditures of $1.36M.